Not Yet Recruiting PHASE1 INTERVENTIONAL 2-arm
NCT06793514
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis: a Double-blind Clinical Trial Study
Sponsor: Mohsen Pourazizi
Conditions
Gut -microbiota Gut Microbiome Dysbiosis Ocular Diseases Ocular Dryness Ocular Surface Disease Probiotic
Interventions
Placebo Drug Probiotic
Updated 1 time since 2025 Last updated: Jan 21, 2025 Started: Feb 1, 2025 Primary completion: May 1, 2025 Completion: Jun 1, 2025
Listed as NCT06793514, this PHASE1 trial focuses on Gut -microbiota and Gut Microbiome Dysbiosis and remains actively recruiting participants. Sponsored by Mohsen Pourazizi, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mohsen Pourazizi
Data source: Isfahan University of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.